Overview The Effect of Severe Kidney Impairment on Cenerimod Pharmacokinetics Status: Recruiting Trial end date: 2022-02-01 Target enrollment: Participant gender: Summary To investigate the PK of cenerimod in participants with severe renal impairment as compared to healthy control participants. Phase: Phase 1 Details Lead Sponsor: Idorsia Pharmaceuticals Ltd.